Provided herein are interfering molecules and pharmaceutical combinations comprising such interfering molecules that modulate the Hippo signaling pathway. Also provided are methods of treating and preventing a disease or condition associated disruption of a Hippo signaling pathway component, such as skeletal muscle disorders and cancers, where the method comprises administering to a subject in need thereof an interfering molecule or pharmaceutical composition described herein.
